ANAFILTAMIG
UNII CLZ7R5K76W

Substance Identification & Data

This profile provides standardized clinical and technical data for Anafiltamig, uniquely identified by the FDA Unique Ingredient Identifier (UNII) CLZ7R5K76W.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3009026-69-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

CLZ7R5K76W

CAS Registry Number

3009026-69-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ANAFILTAMIG

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C224712

National Cancer Institute reference terminology for clinical and research data.

INN ID

13438

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Anafiltamig. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ANAFILTAMIG

Common Names & Synonyms

ANAFILTAMIG [INN]

IMMUNOGLOBULIN (H-GAMMA1_L-KAPPA)_(SCFVKH-G1(H-CH2-CH3)-20MER-SCFVKH), ANTI-(HOMO SAPIENS CD79B (IMMUNOGLOBULIN-ASSOCIATED CORECEPTOR CD79 BETA), ANTI-(HOMO SAPIENS CD3E (CD3 EPSILON, LEU-4)) ANDANTI-(HOMO SAPIENS MS4A1 (MEMBRANE-SPANNING 4-DOMAINS SUBFAMILY A MEMBER 1, CD20)), HOMO SAPIENS AND HUMANIZED MONOCLONAL ANTIBODY; TRISPECIFIC, TRIVALENT

External Clinical & Regulatory Resources

Previous UNIICLZ3FU5MNM

Next UNIICLZ9O8P1E5